Neuronetics Revenue and Competitors

Location

$313.4M

Total Funding

Estimated Revenue & Valuation

  • Neuronetics's estimated annual revenue is currently $88.8M per year.(i)
  • Neuronetics received $Undisclosed in venture funding in June 2018.
  • Neuronetics's estimated revenue per employee is $313,750
  • Neuronetics's total funding is $313.4M.

Employee Data

  • Neuronetics has 283 Employees.(i)
  • Neuronetics grew their employee count by 4% last year.

Neuronetics's People

NameTitleEmail/Phone
1
Sr. VP, Human ResourcesReveal Email/Phone
2
SVP R&D and ClinicalReveal Email/Phone
3
VP, Regulatory Affairs and Quality AssuranceReveal Email/Phone
4
VP Corporate ControllerReveal Email/Phone
5
VP SalesReveal Email/Phone
6
VP National AccountsReveal Email/Phone
7
VP MarketingReveal Email/Phone
8
VP International commercial devReveal Email/Phone
9
VP SalesReveal Email/Phone
10
Head Cybersecurity & ComplianceReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$73.5M29312%N/AN/A
#2
$7M28-10%N/AN/A
#3
$37.9M15113%N/AN/A
#4
$2.1M17-78%$64.3MN/A
#5
$9.3M37-10%N/AN/A
#6
$56.2M1790%N/AN/A
#7
$38.9M155-1%N/AN/A
#8
$22.1M885%N/AN/A
#9
$22.1M889%N/AN/A
#10
$33.4M13310%N/AN/A
Add Company

What Is Neuronetics?

With NeuroStar Advanced Therapy, Neuronetics, Inc., is the market leader in Transcranial Magnetic Stimulation technology for the treatment of Major Depressive Disorder. Based in Malvern, PA, we are a public medical device company (STIM) focused on developing non-invasive therapies for psychiatric and neurological disorders using MRI-strength magnetic field pulses. We are the first company to have a non-systemic and non-invasive depression treatment cleared by the FDA for patients who have not benefited from prior antidepressant medication. Neuronetics markets NeuroStar Advanced Therapy throughout the United States and select markets around the world. If you have questions or comments about NeuroStar, please e-mail us at customersupport@neuronetics.com. For U.S. phone support, please call us at (877) 600-7555, for international customers, our number is +1 (610) 640-4207.

keywords:N/A

$313.4M

Total Funding

283

Number of Employees

$88.8M

Revenue (est)

4%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Neuronetics News

2022-04-20 - 2022-04-28 | NDAQ:STIM | Press Release | Neuronetics Inc.

Neuronetics to Report First Quarter 2022 Financial and Operating Results and Host Conference Call. STIM | 6 hours ago. MALVERN, Pa., April 28,...

2022-04-20 - Neuronetics to Report First Quarter 2022 Financial and Operating Results and Host Conference Call - Benzi

Neuronetics, Inc. believes that mental health is as important as physical health. As a global leader in neuroscience and the largest TMS...

2022-04-06 - Greenbrook and Neuronetics Announce Strengthened ...

Greenbrook and Neuronetics Announce Strengthened Commercial Partnership to Build Awareness. April 11, 2022 08:00 ET | Source: Neuronetics; Greenbrook TMS...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$7.5M285-2%N/A
#2
$56.8M287-2%N/A
#3
$38.8M3104%N/A
#4
$67.3M327N/AN/A
#5
$160.2M3296%$40M

Neuronetics Funding

DateAmountRoundLead InvestorsReference
2009-09-03$30.0MDNLV PartnersArticle
2015-04-28$34.3MFGE VenturesArticle
2017-06-07$15.0MGAscension VenturesArticle
2018-06-01$UndisclosedUndisclosedPiper Jaffray & Co.Article